Used as a key intermediate in the synthesis of certain central nervous system (CNS) active pharmaceuticals, particularly in the production of selective norepinephrine reuptake inhibitors. Its chiral structure makes it valuable for developing enantiomerically pure drugs targeting depression and attention-deficit disorders. The compound’s functional groups allow for further chemical modifications, enabling the creation of derivatives with optimized pharmacokinetic and pharmacodynamic properties. It is primarily employed in research and development settings for novel antidepressants and related therapeutic agents.